The study to understand and overcome psychiatric and neurological disorders from an investigation of rapid eye movement (REM) sleep. -The significance of decrease in REM sleep by an analysis of metabolomes in patients with obstructive sleep apnea before and following the treatment
Not Applicable
Recruiting
- Conditions
- OSAS patients whose REM sleep duration is less than 12% of their total sleep duration measured by PSG
- Registration Number
- JPRN-UMIN000045835
- Lead Sponsor
- ihon University of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who were already diagnosed with sleep apnea syndrome and treated. 2. Patients with hemodialysis 3. Patients with cancer 4. Patients on oxygen therapy 5. Patients with a cardiac pacemaker 6. Physically disabled patients 7. Patients who refuse to participate in this trial 8. Patients who are judged as inappropriate candidates by doctors
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Investigation of specific metabolomes and their concentrations which would appear according to changes in REM sleep duration in patients with OSAS before and following CPAP treatment
- Secondary Outcome Measures
Name Time Method Changes in REM sleep duration and ratio to total sleep duration in the patients with OSAS before and following CPAP treatment